Literature DB >> 30950126

Tao-Hong-Si-Wu decoction reduces ischemia reperfusion rat myoblast cells calcium overloading and inflammation through the Wnt/IP3R/CAMKII pathway.

Zhu Fuping1, Li Wuping1, Wang Linhua1, Pan Chengxi1, Zhou Fuqiang1, Zhang Yi1, Wang Aijun1.   

Abstract

Limb ischemia reperfusion (LIRI) injury is associated with serious local and systemic effects. Reperfusion may augment tissue injury in excess of that produced by ischemia alone. Calcium overloading and inflammation are considered to be two of the pathological mechanisms of limb ischemia/reperfusion (I/R) injury. Tao-Hong-Si-Wu decoction (THSWD) is a traditional Chinese herbal medicine with a powerful anti-inflammatory properties. We studied the probable restorative effect of THSWD on limb I/R-induced calcium overloading and inflammation in myoblast obtained from gastrocnemius muscle tissues of Sprague-Dawley rats (Frizzled Z5,a wnt5a blocker; KN-93, a calmodulin-dependent protein kinase II (CamkII) blocker; XeC, a IP3R blocker as positive controls). The simulated ischemia and reperfusion(I/R) solutions were used to imitate LIRI environment. The results showed that after I/R treatment, the secretion of proinflammatory factors (TNF-α and IL-1β) and Wnt5a/Ca2+ signal molecules (wnt5a, camkII, and IP3R) upregulated significantly, the Ca2+ concentration enhanced too in myoblast cells. THSWD pretreatment decreased the secretion of TNF-α and IL-1β, Ca2+ concentration; and abated the Wnt5a/Ca2+ signal molecules of wnt5a, camkII and IP3R expression activated by I/R injury; but could not abated the Wnt11 and protein kinase C (PKC) expression significantly, the results was similar with Frizzled Z5 treatment cells. Our research illustrated that THSWD may have a mitigating effect on LIRI targeting Wnt/IP3R/CAMKII but not Wnt/IP3R/PKC signaling pathway for the first time. This study may encourage the use of THSWD in the critical clinical settings with LIRI.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  LIRI; THSWD; Tao-Hong-Si-Wu decocotion; Wnt/IP3R/CAMKII; limb ischemia reperfusion

Year:  2019        PMID: 30950126     DOI: 10.1002/jcb.28582

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  4 in total

1.  Taohuajing reduces oxidative stress and inflammation in diabetic cardiomyopathy through the sirtuin 1/nucleotide-binding oligomerization domain-like receptor protein 3 pathway.

Authors:  Rui Yao; Yu Cao; Changming Wang; Lu Xu; Xuan Zhang; Yuqing Deng; Feng Li; Siwang Wang
Journal:  BMC Complement Med Ther       Date:  2021-02-26

2.  Modified Taohong Siwu decoction improves cardiac function after myocardial ischaemia and reperfusion in rats by promoting endogenous stem cell mobilization and regulating metabolites.

Authors:  Wan-Ting Meng; Zhong-Xin Xiao; Han Li; Ya-Chao Wang; Yue Zhao; Yan Zhu; Hai-Dong Guo
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

3.  Taohong Siwu Decoction Promotes Osteo-Angiogenesis in Fractures by Regulating the HIF-1α Signaling Pathway.

Authors:  Zhi Tang; Ming Yin; Yuxing Guo; Wei Li; Fei Sun; Yonglin Guo; Zhenzhong Chen; Biao Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-20       Impact factor: 2.650

4.  Effects of cyclosporin A pre-treatment combined with etomidate post-treatment on lung injury induced by limb ischemia-reperfusion in rats.

Authors:  Haibo Zou; Xiaofeng Sun
Journal:  J Int Med Res       Date:  2020-07       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.